Treatment with mesoridazine and thioridazine in chronic schizophrenia: II. Potential predictors of drug response.
D000328:Adult; D002908:Chronic Disease; D003072:Cognition Disorders / Q000188:drug therapy; D003265:Contingent Negative Variation; D005260:Female; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D008297:Male; D008653:Mesoridazine / Q000627:therapeutic use*; D008875:Middle Aged; D011379:Prognosis; D011930:Reaction Time / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D012737:Sex Factors; D013881:Thioridazine / Q000627:therapeutic use*; D014851:Wakefulness / Q000187:drug effects
D008653:Mesoridazine; D013881:Thioridazine